The Challenges of Pediatric to Adult Care Transitions for Sickle Cell Disease Patients
Young adulthood is one of the most exciting times in life. It is full of new experiences, challenges, freedoms, and responsibilities. Young adults living with a chronic medical condition have [...]
COVID-19 and Sickle Cell Disease
In the midst of the COVID-19 pandemic, sickle cell disease patients, their caregivers, and their physicians are challenged to find ways to avoid hospital visits, manage acute pain crises at [...]
Three Developments That Will Irreversibly Shape the Sickle Cell Disease Therapy Market
Investment in R&D is set to deliver much-needed, potentially disease-modifying therapies for people with sickle cell disease (SCD), especially those with severe disease. Severe disease is characterized by frequent [...]
Seven Questions I Would Ask (and Answer) If I Were Developing a New Drug for Sickle Cell Disease
The last six months have delivered a wave of clinical, commercial, and regulatory developments regarding the treatment of sickle cell disease (SCD). Indeed, the U.S. launch of two new [...]
The Challenges of Pediatric to Adult Care Transitions for Sickle Cell Disease Patients
Young adulthood is one of the most exciting times in life. It is full of new experiences, challenges, freedoms, and responsibilities. Young adults living with a chronic medical condition have [...]
COVID-19 and Sickle Cell Disease
In the midst of the COVID-19 pandemic, sickle cell disease patients, their caregivers, and their physicians are challenged to find ways to avoid hospital visits, manage acute pain crises at [...]
Three Developments That Will Irreversibly Shape the Sickle Cell Disease Therapy Market
Investment in R&D is set to deliver much-needed, potentially disease-modifying therapies for people with sickle cell disease (SCD), especially those with severe disease. Severe disease is characterized by frequent [...]
Seven Questions I Would Ask (and Answer) If I Were Developing a New Drug for Sickle Cell Disease
The last six months have delivered a wave of clinical, commercial, and regulatory developments regarding the treatment of sickle cell disease (SCD). Indeed, the U.S. launch of two new [...]